207 related articles for article (PubMed ID: 23067021)
21. Screening for mutations in two exons of FANCG gene in Pakistani population.
Aymun U; Iram S; Aftab I; Khaliq S; Nadir A; Nisar A; Mohsin S
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Jun; 161(2):158-163. PubMed ID: 28627524
[TBL] [Abstract][Full Text] [Related]
22. Investigation of Fanconi anemia protein interactions by yeast two-hybrid analysis.
Huber PA; Medhurst AL; Youssoufian H; Mathew CG
Biochem Biophys Res Commun; 2000 Feb; 268(1):73-7. PubMed ID: 10652215
[TBL] [Abstract][Full Text] [Related]
23. Spectrum of sequence variation in the FANCG gene: an International Fanconi Anemia Registry (IFAR) study.
Auerbach AD; Greenbaum J; Pujara K; Batish SD; Bitencourt MA; Kokemohr I; Schneider H; Lobitzc S; Pasquini R; Giampietro PF; Hanenberg H; Levran O;
Hum Mutat; 2003 Feb; 21(2):158-68. PubMed ID: 12552564
[TBL] [Abstract][Full Text] [Related]
24. Strong FANCA/FANCG but weak FANCA/FANCC interaction in the yeast 2-hybrid system.
Reuter T; Herterich S; Bernhard O; Hoehn H; Gross HJ
Blood; 2000 Jan; 95(2):719-20. PubMed ID: 10627486
[TBL] [Abstract][Full Text] [Related]
25. Endocrine profiling in patients with Fanconi anemia, homozygous for a FANCG founder mutation.
Dillon B; Feben C; Segal D; du Plessis J; Reynders D; Wainwright R; Poole J; Krause A
Mol Genet Genomic Med; 2020 Aug; 8(8):e1351. PubMed ID: 32529760
[TBL] [Abstract][Full Text] [Related]
26. Spectrum of sequence variations in the FANCA gene: an International Fanconi Anemia Registry (IFAR) study.
Levran O; Diotti R; Pujara K; Batish SD; Hanenberg H; Auerbach AD
Hum Mutat; 2005 Feb; 25(2):142-9. PubMed ID: 15643609
[TBL] [Abstract][Full Text] [Related]
27. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
[TBL] [Abstract][Full Text] [Related]
28. Fanconi anemia founder mutation in Macedonian patients.
Madjunkova S; Kocheva SA; Plaseska-Karanfilska D
Acta Haematol; 2014; 132(1):15-21. PubMed ID: 24356203
[TBL] [Abstract][Full Text] [Related]
29. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.
Faivre L; Guardiola P; Lewis C; Dokal I; Ebell W; Zatterale A; Altay C; Poole J; Stones D; Kwee ML; van Weel-Sipman M; Havenga C; Morgan N; de Winter J; Digweed M; Savoia A; Pronk J; de Ravel T; Jansen S; Joenje H; Gluckman E; Mathew CG
Blood; 2000 Dec; 96(13):4064-70. PubMed ID: 11110674
[TBL] [Abstract][Full Text] [Related]
30. Severe telomere shortening in Fanconi anemia complementation group L.
Shah A; George M; Dhangar S; Rajendran A; Mohan S; Vundinti BR
Mol Biol Rep; 2021 Jan; 48(1):585-593. PubMed ID: 33394227
[TBL] [Abstract][Full Text] [Related]
31. Characterization of two novel FANCG mutations in Indian Fanconi anemia patients.
Solanki A; Kumar Selvaa C; Sheth F; Radhakrishnan N; Kalra M; Vundinti BR
Leuk Res; 2017 Feb; 53():50-56. PubMed ID: 28024295
[TBL] [Abstract][Full Text] [Related]
32. A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA.
Waisfisz Q; de Winter JP; Kruyt FA; de Groot J; van der Weel L; Dijkmans LM; Zhi Y; Arwert F; Scheper RJ; Youssoufian H; Hoatlin ME; Joenje H
Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10320-5. PubMed ID: 10468606
[TBL] [Abstract][Full Text] [Related]
33. Hematological consequences of a FANCG founder mutation in Black South African patients with Fanconi anemia.
Feben C; Kromberg J; Wainwright R; Stones D; Poole J; Haw T; Krause A
Blood Cells Mol Dis; 2015 Mar; 54(3):270-4. PubMed ID: 25477267
[TBL] [Abstract][Full Text] [Related]
34. Continuous in vivo infusion of interferon-gamma (IFN-gamma) enhances engraftment of syngeneic wild-type cells in Fanca-/- and Fancg-/- mice.
Si Y; Ciccone S; Yang FC; Yuan J; Zeng D; Chen S; van de Vrugt HJ; Critser J; Arwert F; Haneline LS; Clapp DW
Blood; 2006 Dec; 108(13):4283-7. PubMed ID: 16946306
[TBL] [Abstract][Full Text] [Related]
35. Functional analysis of patient-derived mutations in the Fanconi anemia gene, FANCG/XRCC9.
Nakanishi K; Moran A; Hays T; Kuang Y; Fox E; Garneau D; Montes de Oca R; Grompe M; D'Andrea AD
Exp Hematol; 2001 Jul; 29(7):842-9. PubMed ID: 11438206
[TBL] [Abstract][Full Text] [Related]
36. Fanconi Anemia Patients from an Indigenous Community in Mexico Carry a New Founder Pathogenic Variant in
Reyes P; García-de Teresa B; Juárez U; Pérez-Villatoro F; Fiesco-Roa MO; Rodríguez A; Molina B; Villarreal-Molina MT; Meléndez-Zajgla J; Carnevale A; Torres L; Frias S
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216452
[TBL] [Abstract][Full Text] [Related]
37. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
38. Esophageal cancer as initial presentation of Fanconi anemia in patients with a hypomorphic
Lach FP; Singh S; Rickman KA; Ruiz PD; Noonan RJ; Hymes KB; DeLacure MD; Kennedy JA; Chandrasekharappa SC; Smogorzewska A
Cold Spring Harb Mol Case Stud; 2020 Dec; 6(6):. PubMed ID: 33172906
[TBL] [Abstract][Full Text] [Related]
39. Carboxy terminal region of the Fanconi anemia protein, FANCG/XRCC9, is required for functional activity.
Kuang Y; Garcia-Higuera I; Moran A; Mondoux M; Digweed M; D'Andrea AD
Blood; 2000 Sep; 96(5):1625-32. PubMed ID: 10961856
[TBL] [Abstract][Full Text] [Related]
40. [Construction of FANCA mutant protein from Fanconi anemia patient and analysis of its function].
Chen F; Zhang KJ; Zuo XL; Zeng XC
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):741-4. PubMed ID: 18457264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]